G Guglielmini Selected Research

1,2,6,7,8,8a- hexahydro- beta,delta,6- trihydroxy- 2- methyl- 8- (2- methyl- 1- oxobutoxy)- 1- naphthaleneheptanoic acid 4-(nitrooxy)butyl ester

11/2005

A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G Guglielmini Research Topics

Disease

3	Thrombosis (Thrombus) 01/2019 - 01/2009
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2012 - 01/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2009
1	Thrombasthenia (Glanzmann Thrombasthenia) 05/2008
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 05/2008
1	Pulmonary Embolism 11/2005

Drug/Important Bio-Agent (IBA)

1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Biological ProductsIBA 01/2019
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2012
1	VitaminsIBA 01/2009
1	AntioxidantsIBA 01/2009
1	Antiphospholipid AntibodiesIBA 01/2009
1	Estrogens (Estrogen)FDA Link 01/2009
1	ParaproteinsIBA 05/2008
1	IsoantibodiesIBA 05/2008
1	AutoantibodiesIBA 05/2008
1	1,2,6,7,8,8a- hexahydro- beta,delta,6- trihydroxy- 2- methyl- 8- (2- methyl- 1- oxobutoxy)- 1- naphthaleneheptanoic acid 4-(nitrooxy)butyl esterIBA 11/2005
1	Epinephrine (Adrenaline)FDA LinkGeneric 11/2005
1	CollagenIBA 11/2005

Therapy/Procedure

1	Therapeutics 01/2009